JUN TERUYA to Humans
This is a "connection" page, showing publications JUN TERUYA has written about Humans.
Connection Strength
0.721
-
Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood. Arch Pathol Lab Med. 2024 01 01; 148(1):11-12.
Score: 0.023
-
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost. 2024 Feb; 50(1):81-90.
Score: 0.021
-
Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
Score: 0.020
-
Convalescent plasma in hospitalized pediatric and obstetric coronavirus disease 2019 (COVID-19) patients. Pediatr Int. 2022 Jan; 64(1):e15407.
Score: 0.020
-
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods. Int J Lab Hematol. 2022 Jun; 44(3):589-594.
Score: 0.020
-
Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state. Int J Lab Hematol. 2021 Oct; 43(5):1216-1224.
Score: 0.019
-
Evaluation and Management of Coagulopathies and Thrombophilias in Pediatric Patients. Clin Lab Med. 2021 03; 41(1):83-100.
Score: 0.018
-
Low antithrombin levels in neonates and infants undergoing congenital heart surgery result in more red blood cell and plasma transfusion on cardiopulmonary bypass. Transfusion. 2020 12; 60(12):2841-2848.
Score: 0.018
-
C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII. Int J Lab Hematol. 2021 Feb; 43(1):139-142.
Score: 0.018
-
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2020 Feb; 46(1):62-72.
Score: 0.017
-
Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing. Thromb Res. 2020 02; 186:54-57.
Score: 0.017
-
Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients: A Single Institution's Experience. Pediatr Crit Care Med. 2019 10; 20(10):980-985.
Score: 0.017
-
Perturbation of Hemostatic Function by Nonbiologic Surfaces. Semin Thromb Hemost. 2018 02; 44(1):5-6.
Score: 0.015
-
Management of Hemostasis for Pediatric Patients on Ventricular-Assist Devices. Semin Thromb Hemost. 2018 Feb; 44(1):30-37.
Score: 0.015
-
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2018 Feb; 44(1):20-29.
Score: 0.015
-
From Z to A: Putting Zika virus in perspective. J Thorac Cardiovasc Surg. 2017 07; 154(1):303-304.
Score: 0.014
-
PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns. J Neonatal Perinatal Med. 2016 May 18; 9(2):139-43.
Score: 0.013
-
Utility of ADAMTS13 assays in diagnosing thrombotic thrombocytopenic purpura. In reply. Arch Pathol Lab Med. 2015 Apr; 139(4):433-4.
Score: 0.012
-
The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014 Nov; 138(11):1503-6.
Score: 0.012
-
Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
Score: 0.012
-
Serologic findings of RhD alleles in Egyptians and their clinical implications. Transfus Apher Sci. 2014 Oct; 51(2):184-7.
Score: 0.012
-
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
Score: 0.012
-
Integration of the transfusion medicine and coagulation services. Transfusion. 2014 May; 54(5):1440-1.
Score: 0.012
-
Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura. Arch Pathol Lab Med. 2014 Apr; 138(4):546-9.
Score: 0.012
-
Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med. 2014 Feb; 15(2):178-9.
Score: 0.011
-
Weak D types in the Egyptian population. Am J Clin Pathol. 2013 Jun; 139(6):806-11.
Score: 0.011
-
Complications of anticoagulation. Dis Mon. 2012 Aug; 58(8):440-7.
Score: 0.010
-
Practice guidelines for reversal of new and old anticoagulants. Dis Mon. 2012 Aug; 58(8):448-61.
Score: 0.010
-
Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis. J Pediatr Adolesc Gynecol. 2012 Aug; 25(4):233-7.
Score: 0.010
-
Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Transfusion. 2012 Nov; 52(11):2321-8.
Score: 0.010
-
Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO. J Extra Corpor Technol. 2011 Jun; 43(2):64-9.
Score: 0.009
-
Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010 Dec; 134(6):950-4.
Score: 0.009
-
Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases. Congenit Heart Dis. 2010 May-Jun; 5(3):303-8.
Score: 0.009
-
Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med. 2009 Jun; 29(2):391-407.
Score: 0.008
-
Parameters of thromboelastography in healthy newborns. Am J Clin Pathol. 2008 Jul; 130(1):99-102.
Score: 0.008
-
Lupus anticoagulant assays: questions answered and to be answered. Arch Pathol Lab Med. 2007 Jun; 131(6):885-9.
Score: 0.007
-
A practical approach to pediatric patients referred with an abnormal coagulation profile. Arch Pathol Lab Med. 2005 Aug; 129(8):1011-6.
Score: 0.006
-
Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease. Arch Pathol Lab Med. 2005 Jun; 129(6):760-5.
Score: 0.006
-
Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome. Transfusion. 2025 May; 65(5):1001-1006.
Score: 0.006
-
Short-term neurologic outcomes in pediatric extracorporeal membrane oxygenation are proportional to bleeding severity graded by a novel bleeding scale. Perfusion. 2025 Jul; 40(5):1267-1276.
Score: 0.006
-
Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference. Pediatr Crit Care Med. 2024 Jul 01; 25(7):643-675.
Score: 0.006
-
Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference. Pediatr Crit Care Med. 2024 Jul 01; 25(7 Suppl 1):e35-e43.
Score: 0.006
-
The Impact of Acute Exercise on Hemostasis and Angiogenesis Mediators in Patients With Continuous-Flow Left Ventricular Assist Devices: A Prospective Observational Pilot Study. ASAIO J. 2025 Jan 01; 71(1):11-20.
Score: 0.006
-
Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke. 2004 Jan; 35(1):175-8.
Score: 0.006
-
Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2024 Feb; 38(2):388-393.
Score: 0.006
-
Long-term implantable ventricular assist device support in children. J Thorac Cardiovasc Surg. 2024 04; 167(4):1417-1426.e1.
Score: 0.006
-
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee. J Thromb Haemost. 2023 01; 21(1):164-174.
Score: 0.005
-
Ventricular assist device support for failing Glenn circulation: Impact of concomitant Fontan completion in select patients. J Heart Lung Transplant. 2023 05; 42(5):637-644.
Score: 0.005
-
Outcomes of temporary ventricular assist device: A?pediatric institutional experience over 25 years. J Thorac Cardiovasc Surg. 2023 07; 166(1):201-211.e2.
Score: 0.005
-
A preventable death: Fatal stroke due to severe iron deficiency anemia. Pediatr Blood Cancer. 2023 03; 70(3):e30014.
Score: 0.005
-
Blood transfusion is associated with increased mortality for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation support. Vox Sang. 2022 Dec; 117(12):1391-1397.
Score: 0.005
-
Practical issues in therapeutic apheresis. Ther Apher. 2002 Aug; 6(4):288-9.
Score: 0.005
-
Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thromb Haemost. 2022 07; 20(7):1735-1743.
Score: 0.005
-
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. Ann Thorac Surg. 2022 03; 113(3):1026-1035.
Score: 0.005
-
Blood, Sweat, and Fears: A Novel Mutation Associated With Anaphylaxis and Nonresponse in a Patient With Afibrinogenemia. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e260-e263.
Score: 0.005
-
Structural characterization of a clinically described heparin-like substance in plasma causing bleeding. Carbohydr Polym. 2020 Sep 15; 244:116443.
Score: 0.004
-
Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood. Sci Rep. 2020 04 01; 10(1):5742.
Score: 0.004
-
Antithrombin Population Pharmacokinetics in Pediatric Ventricular Assist Device Patients. Pediatr Crit Care Med. 2019 12; 20(12):1157-1163.
Score: 0.004
-
Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019 10; 221(4):337.e1-337.e5.
Score: 0.004
-
Severe hypocalcemia during surgery for placenta accreta spectrum: The case for empiric replacement. Acta Obstet Gynecol Scand. 2019 10; 98(10):1326-1331.
Score: 0.004
-
Coagulopathy in surgical management of placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2019 Jun; 237:126-130.
Score: 0.004
-
Centrifugal-flow ventricular assist device support in children: A single-center experience. J Thorac Cardiovasc Surg. 2019 04; 157(4):1609-1617.e2.
Score: 0.004
-
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biol Blood Marrow Transplant. 2019 01; 25(1):157-162.
Score: 0.004
-
In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study. Artif Organs. 2018 Nov; 42(11):1028-1034.
Score: 0.004
-
ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes. Pediatr Transplant. 2018 11; 22(7):e13263.
Score: 0.004
-
Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
Score: 0.004
-
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
Score: 0.004
-
Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
Score: 0.004
-
Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over?time. Am J Obstet Gynecol. 2017 06; 216(6):612.e1-612.e5.
Score: 0.004
-
Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices. Blood. 2015 Nov 12; 126(20):2338-41.
Score: 0.003
-
Neonatal transfusion models to determine the impact of using fresh red blood cells on inventory and exposure. Blood Transfus. 2015 Oct; 13(4):595-9.
Score: 0.003
-
The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant. Pediatr Transplant. 2015 Jun; 19(4):391-8.
Score: 0.003
-
Establishing thromboelastography with platelet-function analyzer reference ranges and other measures in healthy term pregnant women. Am J Perinatol. 2015 May; 32(6):545-54.
Score: 0.003
-
Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015 Feb; 212(2):218.e1-9.
Score: 0.003
-
Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis? Pediatr Blood Cancer. 2014 Nov; 61(11):2074-6.
Score: 0.003
-
Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.
Score: 0.003
-
Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol. 2014 Aug; 31(5):425-34.
Score: 0.003
-
Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia. 2014 Mar; 20(2):249-54.
Score: 0.003
-
Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. Am J Clin Pathol. 2013 Jun; 139(6):812-6.
Score: 0.003
-
Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia. Pediatr Blood Cancer. 2013 Jul; 60(7):1184-7.
Score: 0.003
-
Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med. 2012 Dec; 40(12):3246-50.
Score: 0.003
-
An algorithmic approach to coagulation testing. Dis Mon. 2012 Aug; 58(8):431-9.
Score: 0.003
-
External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med. 2012 Jul; 136(7):789-95.
Score: 0.003
-
Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Ann Pharmacother. 2011 Jul; 45(7-8):876-80.
Score: 0.002
-
Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus. Am J Clin Pathol. 2011 Mar; 135(3):406-16.
Score: 0.002
-
Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer. 2011 Aug; 57(2):294-6.
Score: 0.002
-
External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia. Arch Pathol Lab Med. 2011 Feb; 135(2):227-32.
Score: 0.002
-
Artifact hyperfibrinolysis in thromboelastography with the use of a heparinase cup. Arch Pathol Lab Med. 2010 Dec; 134(12):1736.
Score: 0.002
-
Acquired von Willebrand syndrome and Wilms tumor: not always benign. Pediatr Blood Cancer. 2009 Mar; 52(3):392-4.
Score: 0.002
-
Low prevalence and assay discordance of "aspirin resistance" in children. Pediatr Blood Cancer. 2008 Jul; 51(1):86-92.
Score: 0.002
-
Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2007 Apr; 33(3):250-8.
Score: 0.002
-
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
Score: 0.002
-
Mycophenolate mofetil in the management of alloimmune hemolytic anemia in ABO-compatible but non-identical pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2005 Jul; 41(1):125-8.
Score: 0.002
-
Pathologic quiz case: a 64-year-old man with hematuria, intracranial hemorrhage, and severe coagulation abnormalities. Long-acting warfarin-like rodenticide toxicity. Arch Pathol Lab Med. 2004 Dec; 128(12):e181-2.
Score: 0.002